We are live on ! Find out more
CC

Chicago Capital Portfolio holdings

AUM $4.15B
1-Year Est. Return 31.09%
This Fund
S&P 500
This Quarter Est. Return
+3.21%
1 Year Est. Return
+31.09%
3 Year Est. Return
+117.08%
5 Year Est. Return
+137.61%
10 Year Est. Return
–
AUM
$3.36B
AUM Growth
+$82M
Cap. Flow
+$65.6M
Cap. Flow %
1.95%
Top 10 Hldgs %
33.03%
Holding
318
New
25
Increased
113
Reduced
72
Closed
11

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$22.7M
2
BURL icon
Burlington
BURL
+$14.9M
3
PRCT icon
Procept Biorobotics
PRCT
+$13.9M
4
DELL icon
Dell
DELL
+$10.2M
5
ASML icon
ASML
ASML
+$7.37M

Top Sells

Rank Stock Value
1
DV icon
DoubleVerify
DV
+$45.6M
2
PGR icon
Progressive
PGR
+$16.3M
3
TDC icon
Teradata
TDC
+$14.4M
4
NFLX icon
Netflix
NFLX
+$13.1M
5
TMO icon
Thermo Fisher Scientific
TMO
+$7.45M

Sector Composition

Rank Sector Weight
1 Technology 31.04%
2 Healthcare 18.24%
3 Communication Services 14.1%
4 Financials 12.02%
5 Consumer Discretionary 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
201
AT&T
T
$159B
$658K 0.02%
34,430
+124
+0.4% +$2.16K
FERG icon
202
Ferguson
FERG
$45.4B
$657K 0.02%
3,391
+434
+15% +$91K
MO icon
203
Altria Group
MO
$114B
$641K 0.02%
14,072
+280
+2% +$12.4K
PCTY icon
204
Paylocity
PCTY
$7.38B
$639K 0.02%
4,850
+2,190
+82% +$339K
ADM icon
205
Archer Daniels Midland
ADM
$38.2B
$622K 0.02%
10,295
– –
IVW icon
206
iShares S&P 500 Growth ETF
IVW
$73.8B
$614K 0.02%
6,637
-400
-6% -$34.5K
UNH icon
207
UnitedHealth
UNH
$376B
$608K 0.02%
1,193
-729
-38% -$357K
CTAS icon
208
Cintas
CTAS
$81.9B
$596K 0.02%
3,404
– –
BMY icon
209
Bristol-Myers Squibb
BMY
$133B
$582K 0.02%
14,021
-1,775
-11% -$79.4K
GIS icon
210
General Mills
GIS
$19.1B
$576K 0.02%
9,112
– –
IWN icon
211
iShares Russell 2000 Value ETF
IWN
$14.3B
$564K 0.02%
+3,700
New +$566K
AEP icon
212
American Electric Power
AEP
$69.6B
$557K 0.02%
6,345
– –
SGOL icon
213
abrdn Physical Gold Shares ETF
SGOL
$6.91B
$550K 0.02%
24,740
– –
BAC icon
214
Bank of America
BAC
$435B
$544K 0.02%
13,673
-417
-3% -$16K
BAM icon
215
Brookfield Asset Management
BAM
$77.3B
$540K 0.02%
+14,184
New +$558K
CI icon
216
Cigna
CI
$73.8B
$539K 0.02%
1,632
+124
+8% +$42.8K
SO icon
217
Southern Company
SO
$109B
$538K 0.02%
6,941
– –
FISV
218
Fiserv Inc
FISV
$28.8B
$529K 0.02%
3,551
-15
-0.4% -$2.27K
PH icon
219
Parker-Hannifin
PH
$123B
$529K 0.02%
1,045
+211
+25% +$113K
MDB icon
220
MongoDB
MDB
$27.1B
$520K 0.02%
2,081
-229
-10% -$72.3K
IVE icon
221
iShares S&P 500 Value ETF
IVE
$49B
$515K 0.02%
2,832
– –
VRSK icon
222
Verisk Analytics
VRSK
$25.4B
$511K 0.02%
1,895
– –
AZN icon
223
AstraZeneca
AZN
$263B
$509K 0.02%
3,265
-106
-3% -$16K
MMM icon
224
3M
MMM
$90.9B
$507K 0.02%
4,964
-973
-16% -$94.8K
ET icon
225
Energy Transfer Partners
ET
$70.1B
$507K 0.02%
31,230
-10,841
-26% -$170K
7 8
9
10 11

Similar funds

SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Chicago Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Chicago Capital held 318 positions worth $3.36B, up 2.5% from $3.28B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Chicago Capital's Q2 2024 filing shows 25 new, 113 increased, 72 reduced and 11 closed positions. Its largest new stake was Procept Biorobotics: 232,983 shares worth $14.2M. The largest sale was DoubleVerify, an estimated $45.6M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Communication Services.

  • Chicago Capital's largest Q2 2024 buy was Procept Biorobotics: 232,983 shares worth $14.2M.
  • Chicago Capital added most to Ligand Pharmaceuticals in Q2 2024, an estimated $22.7M increase.
  • Chicago Capital's biggest Q2 2024 reduction was DoubleVerify, cutting an estimated $45.6M.
  • Chicago Capital fully exited lululemon athletica in Q2 2024, selling an estimated $4.4M.
  • Chicago Capital's ten largest holdings make up 33% of its $3.36B portfolio in Q2 2024.
  • Chicago Capital opened 25 new positions and closed 11 in Q2 2024.
  • Chicago Capital's portfolio value rose 2.5% quarter-over-quarter to $3.36B.

Based on Chicago Capital's 13F filing for Q2 2024, filed 6 Aug 2024.